Nationwide Study in France To Predict One Year Major Bleeding and Validate the OAC3-PAD Score in Patients Undergoing Revascularisation for Lower Extremity Arterial Disease

European journal of vascular and endovascular surgery 2023 Aug;66(2):213-219.doi: 10.1016/j.ejvs.2023.04.026. Epub 2023 Apr 28. Fabien Lareyre, Christian-Alexander Behrendt, Christian Pradier, Nicla Settembre, Arindam Chaudhuri, Roxane Fabre, Juliette Raffort, Laurent Bailly Abstract Objective: Antithrombotic strategies are currently recommended for the treatment of lower extremity artery disease (LEAD)

Is Spinal Cord Stimulation Still Effective After One or More Surgical Revisions?

Neuromodulation 2023 Jul;26(5):1102-1108.doi: 10.1016/j.neurom.2023.03.009. Epub 2023 Apr 19. Aurelie Leplus, Jimmy Voirin, Emmanuel Cuny, Marie Onno, Maxime Billot, Philippe Rigoard, Denys Fontaine Abstract Objectives: Spinal cord stimulation (SCS) is burdened with surgical complications that may require one or several surgical revision(s), challenging its risk/benefit ratio and

The Neuropsychiatric Safety Profile of Lasmiditan: A Comparative Disproportionality Analysis with Triptans

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2023 Sep;20(5):1305-1315.doi: 10.1007/s13311-023-01404-1. Epub 2023 Jul 12. Diane Merino, Alexandre O Gérard, Elise K Van Obberghen, Alexandre Destere, Michel Lanteri-Minet, Milou-Daniel Drici Abstract Migraine constitutes the world’s second-leading cause of disability. Triptans, as

Chronic Migraine Epidemiology and Outcomes – International (CaMEO-I) Study: Methods and multi-country baseline findings for diagnosis rates and care

Cephalalgia 2023 Jun;43(6):3331024231180611.doi: 10.1177/03331024231180611. Aubrey Manack Adams, Dawn C Buse, Elizabeth Leroux, Michel Lanteri-Minet, Fumihiko Sakai, Manjit S Matharu, Zaza Katsarava, Michael L Reed, Kristina Fanning, Katherine Sommer, Richard B Lipton Abstract Background: The Chronic Migraine Epidemiology and Outcomes-International study provides insight into people with migraine in multiple countries. Methods:

Formalin-evoked pain triggers sex-specific behavior and spinal immune response

Scientific reports 2023 Jun 12;13(1):9515. doi: 10.1038/s41598-023-36245-7 Lucie Pepino, Pascale Malapert, Andrew J Saurin, Aziz Moqrich, Ana Reynders Abstract Mounting evidence shows sex-related differences in the experience of pain with women suffering more from chronic pain than men. Yet, our understanding of the biological

Joint European Academy of Neurology-European Pain Federation-Neuropathic Pain Special Interest Group of the International Association for the Study of Pain guidelines on neuropathic pain assessment

European journal of neurology 2023 Aug;30(8):2177-2196. doi: 10.1111/ene.15831. Epub 2023 May 30. Andrea Truini, Katina Aleksovska, Christopher C Anderson, Nadine Attal , Ralf Baron , David L Bennett, Didier Bouhassira, Giorgio Cruccu, Elon Eisenberg, Elena Enax-Krumova, Karen Deborah Davis, Giulia Di Stefano, Nanna B Finnerup, Luis Garcia-Larrea, Ibrahem Hanafi , Simon Haroutounian, Pall Karlsson, Martin Rakusa, Andrew S C

Radiosurgery for classical trigeminal neuralgia: impact of the shot size on clinical outcome

The Journal of Headache and Pain 2023 May 11;24(1):51.doi: 10.1186/s10194-023-01583-4. Cécile Ortholan, Philippe Colin, Benjamin Serrano , Thibault Bouet, Nicolas Garnier, Maud le Guyader, Regis Amblard, Rémy Villeneuve, Stéphane Chanalet, Haiel Alchaar, Eric Bozzolo, Michel Lanteri-Minet, Denys Fontaine Abstract Background: This study compares the outcome of patients suffering from medically refractory classical

Efficacy and safety of eptinezumab for migraine prevention in patients with prior preventive treatment failures: subgroup analysis of the randomized, placebo-controlled DELIVER study

Cephalalgia 2023 May;43(5):3331024231170807.doi: 10.1177/03331024231170807. Messoud Ashina, Michel Lanteri-Minet, Anders Ettrup, Cecilie Laurberg Christoffersen, Mette Krog Josiassen, Ravinder Phul, Bjørn Sperling, Patricia Pozo-Rosich Abstract Background: Migraine is a disabling neurological disease adversely affecting many aspects of life. Most patients are still required to have failed several older oral

Course of Headaches and Predictive Factors Associated With Analgesia Failure Following Spontaneous Subarachnoid Hemorrhage: A Prospective Cohort Study

Journal of Neurosurgical anesthesiology 2023 Jul 1;35(3):333-337. doi: 10.1097/ANA.0000000000000843. Epub 2022 May 3. Baptiste Bouchier, Geneviève Demarquay, Frédéric Dailler, Anne-Claire Lukaszewicz, Thomas Ritzenthaler Abstract Background: Headache is the most common presenting symptom of spontaneous subarachnoid hemorrhage and managing this acute pain can be challenging.